Related Experiment Video
Updated: Feb 2, 2026

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts
Published on: October 9, 2016
HGF-induced migration depends on the PI(3,4,5)P3-binding microexon-spliced variant of the Arf6 exchange factor
Colin D H Ratcliffe1,2, Nadeem Siddiqui1,2, Paula P Coelho1,2
1Rosalind and Morris Goodman Cancer Research Centre, McGill University, Montreal, Quebec, Canada.
Abstract:
Differential inclusion or skipping of microexons is an increasingly recognized class of alternative splicing events. However, the functional significance of microexons and their contribution to signaling diversity is poorly understood. The Met receptor tyrosine kinase (RTK) modulates invasive growth and migration in development and cancer. Here, we show that microexon switching in the Arf6 guanine nucleotide exchange factor cytohesin-1 controls Met-dependent cell migration. Cytohesin-1 isoforms, differing by the inclusion of an evolutionarily conserved three-nucleotide microexon in the pleckstrin homology domain, display differential affinity for PI(4,5)P2 (triglycine) and PI(3,4,5)P3 (diglycine). We show that selective phosphoinositide recognition by cytohesin-1 isoforms promotes distinct subcellular localizations, whereby the triglycine isoform localizes to the plasma membrane and the diglycine to the leading edge. These data highlight microexon skipping as a mechanism to spatially restrict signaling and provide a mechanistic link between RTK-initiated phosphoinositide microdomains and Arf6 during signal transduction and cancer cell migration.
Insights
Microexon skipping in cytohesin-1 controls cell migration by altering how it binds to cell membranes. This splicing mechanism spatially restricts signaling, linking receptor tyrosine kinases to Arf6 activity in cancer.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Alternative splicing, particularly microexon inclusion/skipping, is a key mechanism for generating protein diversity.
- The functional roles of microexons and their impact on cellular signaling pathways remain largely unexplored.
- Met receptor tyrosine kinase (RTK) signaling is crucial for regulating cell growth, invasion, and migration in both development and cancer.
Purpose of the Study:
- To investigate the functional significance of microexon switching in cytohesin-1.
- To elucidate the role of cytohesin-1 isoforms in Met-dependent cell migration.
- To understand how microexon variations contribute to Arf6 signaling and phosphoinositide recognition.
Main Methods:
- Analysis of cytohesin-1 isoforms generated by microexon inclusion/skipping.
- Biochemical assays to determine phosphoinositide binding affinities (PI(4,5)P2 and PI(3,4,5)P3) of different cytohesin-1 variants.
- Subcellular localization studies using microscopy to track isoform distribution within migrating cells.
Main Results:
- Cytohesin-1 isoforms, differing by a three-nucleotide microexon, exhibit distinct affinities for PI(4,5)P2 (triglycine isoform) and PI(3,4,5)P3 (diglycine isoform).
- The triglycine cytohesin-1 isoform preferentially localizes to the plasma membrane, while the diglycine isoform is enriched at the leading edge of migrating cells.
- Microexon switching in cytohesin-1 directly influences Met-dependent cancer cell migration by modulating Arf6 activation.
Conclusions:
- Microexon skipping in cytohesin-1 provides a mechanism for spatially regulating signaling pathways.
- Differential phosphoinositide binding by cytohesin-1 isoforms dictates their subcellular localization and function.
- This study establishes a mechanistic link between RTK signaling, phosphoinositide microdomains, and Arf6-mediated cell migration in cancer.
Related Concept Videos
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
RNA Splicing
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
Gas Exchange and Transport

